Malignant Disease in Childhood

  • M. G. Mott
Part of the Developments in Oncology book series (DION, volume 23)

Abstract

Cancer in childhood is fortunately rare, with an approximate annual incidence of 100 cases per million children in the developed world. It is, nevertheless, the commonest disease to kill children in our society and as effective treatment has become available for an increasing proportion of paediatric malignancies so it has become increasingly important to ensure that all effected children receive appropriate therapy. The spectrum of malignant disease is very different in children and adults. Whereas 85? of the tumours in an adult population are carcinomas, this is true of less than 5% of childhood malignancies. Almost half of the malignancies in childhood are leukaemias and lymphomas, and the rest consist primarily of a variety of primitive embryonal tumours that are rarely seen in adults. Failure to appreciate these differences was a major cause for the poor prognosis of paediatric tumours until recently. The primary reason for the improved prognosis in the last two decades has been the development of treatment protocols appropriate for these specific diseases. The overall incidence of childhood cancer has remained stable, but the death rate has fallen successively. The survival rate has more than doubled in the last 20 years (Table 1).

Keywords

Lymphoma Adenocarcinoma Hydrocortisone Shrinkage Oncol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miller DR et al: Prognosic factors and therapy in acute lymphoblastic leukaemia of childhood: CCG-141. Cancer (51): 1041–1049, 1983.PubMedCrossRefGoogle Scholar
  2. 2.
    Riehm H et al: The BFM studies 1970/76 and 1976/79 in childhood acute lymphoblastic leukaemia (ALL). In: Neth R (ed) Modern Advances in Leukemia IV. Springer-Verlag, Berlin, 1981, pp 87–93.Google Scholar
  3. 3.
    Donaldson SS: Hodgkin’s disease. Treatment with low dose radiation and chemotherapy. Front Radiat Ther One (16): 122–133 (Karger, Basel), 1982.Google Scholar
  4. 4.
    D’Angio GJ et al: Wilms′ tumour: An update. Cancer (45): 1791–1798, 1980.PubMedGoogle Scholar
  5. 5.
    Maurer H, Foulkes M, Gehan E: Intergroup rhabdomyosarcoma study (IRS)-II: Preliminary report. Proc. SIOP XV (Abstract): 103, 1983.Google Scholar
  6. 6.
    Price CHG, Jeffree GM: Metastatic spread of osteosarcoma. Br J Cancer (28): 515–524, 1973.PubMedCrossRefGoogle Scholar
  7. 7.
    Rosen G et al: Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer (41): 841–849, 1978.PubMedCrossRefGoogle Scholar
  8. 8.
    Marcove RC, Rosen G: En bloc resections for osteogenic sarcoma. Cancer (45): 3040–3044, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Burgers JMV, Voute PA, van Glabbeke M: 0ERTC-SI0P osteosarcoma trial. Proc SIOP XV (Abstract): 28–29, 1983.Google Scholar
  10. 10.
    Rosen G et al: Preoperative chemotherapy for osteogenic sarcoma. Selection of postoperative adjuvant chemotherapy based on the response of the primary tumour to preoperative chemotherapy. Cancer (49): 1221–1230, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Bloom HJG: Medulloblastoma in children: Increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys (8): 2023–2027, 1982.PubMedCrossRefGoogle Scholar
  12. 12.
    Rubin P, van Houtte P, Constine L: Radiation sensitivity and organ tolerances in pediatric oncology: A new hypothesis. Front Radiat Ther Oncol (16): 62–82 (Karger, Basel), 1982.Google Scholar
  13. 13.
    Meadows AJ et al: Survival in childhood A.L.L. Cancer Investigation (1): 49–55, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Lennox EL et al: Nephroblastoma: The effect on survival of the first MRC trial. Brit Med J (2): 567–569, 1979.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • M. G. Mott

There are no affiliations available

Personalised recommendations